United States· US:58160-848_2522c052-d323-459d-b9fd-76de846bc127
Arexvy
A medicinal product containing respiratory syncytial virus vaccine recombinant, adjuvanted, registered in United States by GlaxoSmithKline Biologicals SA.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted
- Manufacturer
- GlaxoSmithKline Biologicals SA
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- June 3, 2026
Packs & prices · 1
- ndc1158160848111 KIT in 1 CARTON (58160-848-11) * .5 mL in 1 VIAL (58160-723-03) * .5 mL in 1 VIAL (58160-744-03)
Regulatory notes
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/aa02f4b9-0e4e-454d-8d4d-55004effe6a0 GET /v1/drugs/aa02f4b9-0e4e-454d-8d4d-55004effe6a0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": null,
"spl_meta": {
"1e50f275-002e-413f-a840-66ee3cb3740c": {
"match": "brand_token",
"title": "AREXVY (RESPIRATORY SYNCYTIAL VIRUS VACCINE RECOMBINANT, ADJUVANTED) KIT [GLAXOSMITHKLINE BIOLOGICALS SA]",
"spl_version": "10",
"published_date": "2026-05-25"
}
},
"productid": "58160-848_2522c052-d323-459d-b9fd-76de846bc127",
"productndc": "58160-848",
"dosage_form": "KIT",
"dea_schedule": null,
"product_type": "VACCINE",
"substance_name": null,
"proprietary_name": "Arexvy",
"active_ingred_unit": null,
"application_number": "BLA125775",
"marketing_category": "BLA",
"nonproprietary_name": "Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted",
"start_marketing_date": "20230503",
"active_numerator_strength": null
}See everything about respiratory syncytial virus vaccine recombinant, adjuvanted.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.